NCT04081688 2026-02-05
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Rutgers, The State University of New Jersey
Phase 1 Terminated
Clinical Trials
5 trialsNCT03688178 2025-04-15
DERIVe
Duke University
Phase 2 Active not recruiting
NCT02924038 2024-06-14
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
University of California, San Francisco
Phase 1 Terminated
NCT03617328 2024-02-06
Mel-65
University of Virginia
Phase 1/2 Completed
NCT02284971 2018-05-17
Prostate-04
University of Virginia
Phase 1 Terminated